Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Mineralocorticoid receptor antagonist therapy does not significantly reduce mortality in COVID-19 patients.

Baricitinib slightly increased cholesterol levels in alopecia areata patients, but these changes were manageable.

Semifluorinated alkanes are promising for delivering drugs in various medical applications.

No link found between specific genes and female pattern hair loss.

Ritlecitinib effectively reduces severe hair loss in alopecia areata over 24 months.

The drug combination was safe and showed promise in treating advanced tumors.

Finasteride treats enlarged prostate and hair loss, but may cause side effects in some patients.

Certain compounds reduced hamster flank organ size by inhibiting 5α-reductase, like finasteride, without affecting androgen receptors.

Some drugs can reduce male semen quality.

Some medications and supplements can cause serious side effects, including hair loss, heart rhythm problems, liver injury, and other health issues.

Ritlecitinib is generally safe for adolescents with alopecia areata over 5 years.

Baricitinib improved severe hair loss in adults over 52 weeks and was safe to use.

CDK inhibitors may help treat ARDS and psoriasis but need more testing for safety and effectiveness.

Baricitinib was effective in treating a patient with dermatomyositis and hair loss.

New isatin-gallate hybrids show promise as antioxidants, cancer treatments, and coronavirus inhibitors.

Safflower is the most effective in protecting against liver and kidney damage, followed by silymarin and dandelion.

Finasteride shows promise for treating hair loss and excessive hair growth, but more research is needed to confirm its effectiveness and safety.

Talazoparib is more effective than standard chemotherapy for advanced breast cancer with BRCA mutations.

In 2024, the FDA approved 27 innovative small-molecule drugs, with many offering significant treatment improvements.

Ritlecitinib may cause serious side effects like blood clots in alopecia areata patients.

5α-Reductase inhibitors do not consistently increase testosterone levels in the blood.

The authors maintain that shorter androgen receptor alleles may lead to milder COVID-19 by positively affecting the immune response, not due to changes in testosterone levels or activity.

New drugs and therapies targeting specific pathways show promise in treating advanced prostate cancer.

Tofacitinib may effectively treat hair loss and improve symptoms in autoimmune conditions like alopecia areata and Sjögren's syndrome, but long-term treatment might be necessary.

Two existing drugs may help treat COVID-19 by inhibiting a key viral protein.

BBR-SA nanomedicine is a safe and effective treatment for breast cancer.

Excessive eyelash growth from erlotinib may indicate positive tumor response and help treat madarosis.